Scripps Health

 

Scripps Health
N

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Novel Therapeutics

By Scripps Health FEATURING Norman Lepor
By Scripps Health FEATURING Norman Lepor
4,962 views
June 28, 2023
6 Comments
Login to view comments. Click here to Login

Featured Video

04:42
Merck

Epidemiology and Serotypes Associated With Invasive Pneumococcal Dis…

Featured Video

04:59
Merck

Clinical and Public Health Importance of Adult Pneumococcal Disease

2023 Cardiovascular Atherosclerosis: Prediction, Prevention and Management
09:30
Scripps Health

Personalized Medicine and Supplements in Prevention of ACSVD

Feat. C. J. Suhar, E. Muse, R. Khedraki
23:48
Scripps Health

Supplements in Primary and Secondary Prevention of ASCVD

Feat. C. J. Suhar
42:26
Scripps Health

Familial Hypercholesterolemia: From Diagnosis to Treatment

Feat. P. Duell
37:54
Scripps Health

Hypertension in 2023 and Beyond

Feat. L. Laffin
06:23
Scripps Health

Familial Hypercholesterolemia, Dyslipidemia and Lipids: Panel Discus…

Feat. D. Cork, N. Lepor, P. Duell
24:26
Scripps Health

Non-HDL Targets for Risk Reduction

Feat. D. Cork
31:27
Scripps Health

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

Feat. N. Lepor
46:13
Scripps Health

New Concepts in Dyslipidemia: Dispelling Common Health "Truths&…

Feat. D. Triffon
24:30
Scripps Health

Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease

Feat. J. Au
29:51
Scripps Health

Women's Health - Bio-Identical Hormones and Testosterone Supple…

Feat. S. Dalhoumi
39:01
Scripps Health

Obesity and Diabetes Pharmacotherapy: Are You Ready for GLP-1 Agonis…

Feat. S. Harris